TreeWAS – Variant ID: rs16926789

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H11 Other disorders of conjunctiva	0.046	0.954	0.000
H11.8 Other specified disorders of conjunctiva	0.044	0.956	0.000
H11.0 Pterygium	0.044	0.956	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.042	0.958	0.000
H11.3 Conjunctival haemorrhage	0.040	0.960	0.000
H11.1 Conjunctival degenerations and deposits	0.039	0.961	0.000
H11.2 Conjunctival scars	0.033	0.967	0.000
K60.3 Anal fistula	0.031	0.969	0.000
H11.9 Disorder of conjunctiva, unspecified	0.023	0.977	0.000
H10-H13 Disorders of conjunctiva	0.022	0.978	0.000
H10 Conjunctivitis	0.016	0.984	0.000
H13 Disorders of conjunctiva in diseases classified elsewhere	0.016	0.984	0.000
N19 Unspecified renal failure	0.013	0.987	0.000
H10.9 Conjunctivitis, unspecified	0.012	0.988	0.000
H10.8 Other conjunctivitis	0.012	0.988	0.000
H10.5 Blepharoconjunctivitis	0.012	0.988	0.000
H10.4 Chronic conjunctivitis	0.012	0.988	0.000
H10.3 Acute conjunctivitis, unspecified	0.012	0.988	0.000
H10.2 Other acute conjunctivitis	0.012	0.988	0.000
H10.1 Acute atopic conjunctivitis	0.012	0.988	0.000
H10.0 Mucopurulent conjunctivitis	0.012	0.988	0.000
H13.8 Other disorders of conjunctiva in diseases classified elsewhere	0.011	0.988	0.000
H13.3 Ocular pemphigoid	0.011	0.988	0.000
H13.2 Conjunctivitis in other diseases classified elsewhere	0.011	0.988	0.000
H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere	0.011	0.988	0.000
H13.0 Filarial infection of conjunctiva	0.011	0.988	0.000
G44.2 Tension-type headache	0.000	0.991	0.009
I69.3 Sequelae of cerebral infarction	0.009	0.991	0.000
T43.2 Other and unspecified antidepressants	0.000	0.991	0.009
I69 Sequelae of cerebrovascular disease	0.008	0.992	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.008	0.992	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.992	0.008
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.007	0.992	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.993	0.007
I69.1 Sequelae of intracerebral haemorrhage	0.007	0.993	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.993	0.007
R61.9 Hyperhidrosis, unspecified	0.000	0.993	0.007
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.006	0.994	0.000
H91.9 Hearing loss, unspecified	0.006	0.994	0.000
H80.9 Otosclerosis, unspecified	0.006	0.994	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.994	0.006
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.000	0.994	0.006
T43.9 Psychotropic drug, unspecified	0.000	0.994	0.006
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.994	0.006
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.994	0.006
K76.0 Fatty (change of) liver, not elsewhere classified	0.006	0.994	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.006	0.994	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.994	0.005
D47.3 Essential (haemorrhagic) thrombocythaemia	0.005	0.995	0.000
K60 Fissure and fistula of anal and rectal regions	0.005	0.995	0.000
I49.8 Other specified cardiac arrhythmias	0.005	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.995	0.005
H80 Otosclerosis	0.005	0.995	0.000
N17-N19 Renal failure	0.005	0.995	0.000
H91 Other hearing loss	0.005	0.995	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.995	0.005
H81.1 Benign paroxysmal vertigo	0.005	0.995	0.000
H93 Other disorders of ear, not elsewhere classified	0.005	0.995	0.000
H93.1 Tinnitus	0.005	0.995	0.000
H80-H83 Diseases of inner ear	0.005	0.995	0.000
H90-H95 Other disorders of ear	0.005	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.995	0.005
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.995	0.004
N18 Chronic renal failure	0.005	0.995	0.000
T36 Poisoning by systemic antibiotics	0.000	0.995	0.004
U80.8 Agent resistant to other penicillin-related antibiotic	0.004	0.996	0.000
H91.2 Sudden idiopathic hearing loss	0.004	0.996	0.000
K60.5 Anorectal fistula	0.004	0.996	0.000
K60.4 Rectal fistula	0.004	0.996	0.000
N18.3 Chronic kidney disease, stage 3	0.004	0.996	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.996	0.004
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.996	0.004
H93.3 Disorders of acoustic nerve	0.004	0.996	0.000
T46.1 Calcium-channel blockers	0.000	0.996	0.004
N18.5 Chronic kidney disease, stage 5	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.996	0.004
S52.50 Fracture of lower end of radius (closed)	0.000	0.996	0.004
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
H46 Optic neuritis	0.004	0.996	0.000
H81 Disorders of vestibular function	0.004	0.996	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.996	0.004
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.996	0.004
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.996	0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.996	0.004
H93.8 Other specified disorders of ear	0.004	0.996	0.000
N18.4 Chronic kidney disease, stage 4	0.004	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
H80.8 Other otosclerosis	0.004	0.996	0.000
H80.2 Cochlear otosclerosis	0.004	0.996	0.000
H80.1 Otosclerosis involving oval window, obliterative	0.004	0.996	0.000
H80.0 Otosclerosis involving oval window, nonobliterative	0.004	0.996	0.000
T36.0 Penicillins	0.000	0.996	0.004
H91.0 Ototoxic hearing loss	0.004	0.996	0.000
H93.9 Disorder of ear, unspecified	0.004	0.996	0.000
H27.0 Aphakia	0.004	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.996	0.004
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.996	0.004
T46.7 Peripheral vasodilators	0.000	0.996	0.004
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.996	0.004
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.996	0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.996	0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.996	0.004
I60 Subarachnoid haemorrhage	0.004	0.996	0.000
D47.4 Osteomyelofibrosis	0.004	0.996	0.000
H91.3 Deaf mutism, not elsewhere classified	0.004	0.996	0.000
H91.1 Presbycusis	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.996	0.004
Z13.9 Special screening examination, unspecified	0.004	0.996	0.000
H93.2 Other abnormal auditory perceptions	0.004	0.996	0.000
H93.0 Degenerative and vascular disorders of ear	0.004	0.996	0.000
N18.8 Other chronic renal failure	0.004	0.996	0.000
N48.6 Balanitis xerotica obliterans	0.004	0.996	0.000
D47.2 Monoclonal gammopathy	0.004	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.996	0.004
O69.2 Labour and delivery complicated by other cord entanglement	0.000	0.996	0.004
H83 Other diseases of inner ear	0.004	0.996	0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.004	0.996	0.000
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.996	0.004
H21.0 Hyphaema	0.004	0.996	0.000
H44 Disorders of globe	0.004	0.996	0.000
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.004	0.996	0.000
H21 Other disorders of iris and ciliary body	0.004	0.996	0.000
H60 Otitis externa	0.004	0.996	0.000
H43-H45 Disorders of vitreous body and globe	0.004	0.996	0.000
H46-H48 Disorders of optic nerve and visual pathways	0.004	0.996	0.000
K60.0 Acute anal fissure	0.004	0.996	0.000
H82 Vertiginous syndromes in diseases classified elsewhere	0.003	0.996	0.000
H60.3 Other infective otitis externa	0.004	0.996	0.000
T39.0 Salicylates	0.000	0.996	0.004
Chapter VII Diseases of the eye and adnexa	0.004	0.996	0.000
I60.8 Other subarachnoid haemorrhage	0.004	0.996	0.000
H94 Other disorders of ear in diseases classified elsewhere	0.003	0.996	0.000
Chapter VIII Diseases of the ear and mastoid process	0.004	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.996	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.996	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.996	0.003
T42.3 Barbiturates	0.000	0.996	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.996	0.003
T42.0 Hydantoin derivatives	0.000	0.996	0.003
H92 Otalgia and effusion of ear	0.004	0.996	0.000
D47.1 Chronic myeloproliferative disease	0.003	0.996	0.000
N18.1 Chronic kidney disease, stage 1	0.003	0.996	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.996	0.003
T36.8 Other systemic antibiotics	0.000	0.996	0.003
T36.7 Antifungal antibiotics, systemically used	0.000	0.996	0.003
T36.6 Rifamycins	0.000	0.996	0.003
T36.5 Aminoglycosides	0.000	0.996	0.003
T36.4 Tetracyclines	0.000	0.996	0.003
T36.3 Macrolides	0.000	0.996	0.003
T36.2 Chloramphenicol group	0.000	0.996	0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.996	0.003
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.003	0.997	0.000
T42.1 Iminostilbenes	0.000	0.997	0.003
Z43.3 Attention to colostomy	0.000	0.997	0.003
Z91.5 Personal history of self-harm	0.000	0.997	0.003
H34.2 Other retinal artery occlusions	0.003	0.997	0.000
H60.8 Other otitis externa	0.003	0.997	0.000
U89.8 Agent resistant to other single specified antibiotic	0.003	0.997	0.000
H55-H59 Other disorders of eye and adnexa	0.003	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.997	0.003
H21.5 Other adhesions and disruptions of iris and ciliary body	0.003	0.997	0.000
K76.6 Portal hypertension	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
H44.1 Other endophthalmitis	0.003	0.997	0.000
H44.0 Purulent endophthalmitis	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.003
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.003
T38.7 Androgens and anabolic congeners	0.000	0.997	0.003
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.000	0.997	0.003
T38.4 Oral contraceptives	0.000	0.997	0.003
T38.2 Antithyroid drugs	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.000	0.997	0.003
T38.0 Glucocorticoids and synthetic analogues	0.000	0.997	0.003
H60.9 Otitis externa, unspecified	0.003	0.997	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.003	0.997	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.003	0.997	0.000
H21.2 Degeneration of iris and ciliary body	0.003	0.997	0.000
H44.9 Disorder of globe, unspecified	0.003	0.997	0.000
H81.8 Other disorders of vestibular function	0.003	0.997	0.000
H81.4 Vertigo of central origin	0.003	0.997	0.000
H81.3 Other peripheral vertigo	0.003	0.997	0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
H27 Other disorders of lens	0.003	0.997	0.000
H81.9 Disorder of vestibular function, unspecified	0.003	0.997	0.000
H44.4 Hypotony of eye	0.003	0.997	0.000
H83.9 Disease of inner ear, unspecified	0.003	0.997	0.000
H91.8 Other specified hearing loss	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.003
T37.5 Antiviral drugs	0.000	0.997	0.003
T37.4 Anthelminthics	0.000	0.997	0.003
T37.3 Other antiprotozoal drugs	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
T37.1 Antimycobacterial drugs	0.000	0.997	0.003
T37.0 Sulphonamides	0.000	0.997	0.003
T41.5 Therapeutic gases	0.000	0.997	0.003
T41.4 Anaesthetic, unspecified	0.000	0.997	0.003
T41.3 Local anaesthetics	0.000	0.997	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.003
T41.1 Intravenous anaesthetics	0.000	0.997	0.003
T41.0 Inhaled anaesthetics	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.003
T48.5 Anti-common-cold drugs	0.000	0.997	0.003
T48.4 Expectorants	0.000	0.997	0.003
T48.3 Antitussives	0.000	0.997	0.003
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.003
T48.0 Oxytocic drugs	0.000	0.997	0.003
T49.9 Topical agent, unspecified	0.000	0.997	0.003
T49.8 Other topical agents	0.000	0.997	0.003
T49.7 Dental drugs, topically applied	0.000	0.997	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.997	0.003
T49.2 Local astringents and local detergents	0.000	0.997	0.003
T49.1 Antipruritics	0.000	0.997	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.003
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.997	0.003
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.003	0.997	0.000
N48.9 Disorder of penis, unspecified	0.003	0.997	0.000
T50.8 Diagnostic agents	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
K76 Other diseases of liver	0.003	0.997	0.000
H21.8 Other specified disorders of iris and ciliary body	0.003	0.997	0.000
N18.0 End-stage renal disease	0.003	0.997	0.000
H95.1 Other disorders following mastoidectomy	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
H92.0 Otalgia	0.003	0.997	0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.003	0.997	0.000
I60.5 Subarachnoid haemorrhage from vertebral artery	0.003	0.997	0.000
I60.4 Subarachnoid haemorrhage from basilar artery	0.003	0.997	0.000
T40.6 Other and unspecified narcotics	0.000	0.997	0.003
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.003	0.997	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.003	0.997	0.000
H60-H62 Diseases of external ear	0.003	0.997	0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.003
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
T47.7 Emetics	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.003
T47.5 Digestants	0.000	0.997	0.003
T47.4 Other laxatives	0.000	0.997	0.003
T47.3 Saline and osmotic laxatives	0.000	0.997	0.003
T47.2 Stimulant laxatives	0.000	0.997	0.003
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.003
T42.4 Benzodiazepines	0.000	0.997	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
H83.8 Other specified diseases of inner ear	0.003	0.997	0.000
H43 Disorders of vitreous body	0.003	0.997	0.000
F31.9 Bipolar affective disorder, unspecified	0.000	0.997	0.003
R61 Hyperhidrosis	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.997	0.003
T39.4 Antirheumatics, not elsewhere classified	0.000	0.997	0.003
T39.2 Pyrazolone derivatives	0.000	0.997	0.003
H60.5 Acute otitis externa, non-infective	0.003	0.997	0.000
H83.3 Noise effects on inner ear	0.003	0.997	0.000
H83.2 Labyrinthine dysfunction	0.003	0.997	0.000
H83.1 Labyrinthine fistula	0.003	0.997	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.003	0.997	0.000
H95.9 Postprocedural disorder of ear and mastoid process, unspecified	0.003	0.997	0.000
H95.8 Other postprocedural disorders of ear and mastoid process	0.003	0.997	0.000
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity	0.003	0.997	0.000
N48.1 Balanoposthitis	0.003	0.997	0.000
H44.8 Other disorders of globe	0.003	0.997	0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.003	0.997	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.003	0.997	0.000
H44.5 Degenerated conditions of globe	0.003	0.997	0.000
H44.3 Other degenerative disorders of globe	0.003	0.997	0.000
M46.9 Inflammatory spondylopathy, unspecified	0.000	0.997	0.003
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.003
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.003
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.003
T45.4 Iron and its compounds	0.000	0.997	0.003
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.997	0.003
N48 Other disorders of penis	0.003	0.997	0.000
H21.9 Disorder of iris and ciliary body, unspecified	0.003	0.997	0.000
H21.4 Pupillary membranes	0.003	0.997	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.003	0.997	0.000
H60.4 Cholesteatoma of external ear	0.003	0.997	0.000
H60.2 Malignant otitis externa	0.003	0.997	0.000
H60.0 Abscess of external ear	0.003	0.997	0.000
K74.6 Other and unspecified cirrhosis of liver	0.003	0.997	0.000
T39.1 4-Aminophenol derivatives	0.000	0.997	0.003
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.003	0.997	0.000
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.003	0.997	0.000
K75.9 Inflammatory liver disease, unspecified	0.003	0.997	0.000
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere	0.003	0.997	0.000
I60-I69 Cerebrovascular diseases	0.003	0.997	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.003	0.997	0.000
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.003	0.997	0.000
H57.1 Ocular pain	0.003	0.997	0.000
H57 Other disorders of eye and adnexa	0.003	0.997	0.000
I60.9 Subarachnoid haemorrhage, unspecified	0.003	0.997	0.000
H81.2 Vestibular neuronitis	0.003	0.997	0.000
N48.5 Ulcer of penis	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.003
H34 Retinal vascular occlusions	0.003	0.997	0.000
H92.2 Otorrhagia	0.003	0.997	0.000
H94.8 Other specified disorders of ear in diseases classified elsewhere	0.003	0.997	0.000
H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
K60.1 Chronic anal fissure	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.997	0.003
H60.1 Cellulitis of external ear	0.003	0.997	0.000
H43.3 Other vitreous opacities	0.003	0.997	0.000
T45.5 Anticoagulants	0.000	0.997	0.003
U80 Agent resistant to penicillin and related antibiotics	0.003	0.997	0.000
H83.0 Labyrinthitis	0.003	0.997	0.000
N17 Acute renal failure	0.003	0.997	0.000
H25-H28 Disorders of lens	0.003	0.997	0.000
K75 Other inflammatory liver diseases	0.003	0.997	0.000
I61.8 Other intracerebral haemorrhage	0.003	0.997	0.000
I61 Intracerebral haemorrhage	0.003	0.997	0.000
U89 Agent resistant to other and unspecified antibiotics	0.003	0.997	0.000
K75.4 Autoimmune hepatitis	0.003	0.997	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.002	0.997	0.000
H27.8 Other specified disorders of lens	0.003	0.997	0.000
H43.1 Vitreous haemorrhage	0.003	0.997	0.000
N05.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)	0.000	0.997	0.003
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.000	0.997	0.003
H27.9 Disorder of lens, unspecified	0.002	0.997	0.000
N18.2 Chronic kidney disease, stage 2	0.002	0.997	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.003	0.997	0.000
H43.2 Crystalline deposits in vitreous body	0.003	0.997	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.003	0.997	0.000
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.000	0.997	0.003
M07.3 Other psoriatic arthropathies	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.997	0.002
T40.8 Lysergide [LSD]	0.000	0.997	0.002
T40.7 Cannabis (derivatives)	0.000	0.997	0.002
T40.5 Cocaine	0.000	0.997	0.002
T40.3 Methadone	0.000	0.997	0.002
T40.1 Heroin	0.000	0.997	0.002
T40.0 Opium	0.000	0.997	0.002
H20 Iridocyclitis	0.003	0.997	0.000
R61.0 Localised hyperhidrosis	0.000	0.997	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.997	0.002
H43.9 Disorder of vitreous body, unspecified	0.002	0.997	0.000
H57.0 Anomalies of pupillary function	0.002	0.997	0.000
K76.5 Hepatic veno-occlusive disease	0.002	0.997	0.000
K76.4 Peliosis hepatis	0.002	0.997	0.000
K76.3 Infarction of liver	0.002	0.997	0.000
K76.2 Central haemorrhagic necrosis of liver	0.002	0.997	0.000
K76.1 Chronic passive congestion of liver	0.002	0.997	0.000
H34.1 Central retinal artery occlusion	0.002	0.997	0.000
N48.4 Impotence of organic origin	0.003	0.997	0.000
H44.2 Degenerative myopia	0.002	0.997	0.000
H58.9 Other specified disorders of eye and adnexa in diseases classified elsewhere	0.002	0.997	0.000
H58.1 Visual disturbances in diseases classified elsewhere	0.002	0.997	0.000
H58.0 Anomalies of pupillary function in diseases classified elsewhere	0.002	0.997	0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.002	0.997	0.000
H15 Disorders of sclera	0.002	0.997	0.000
H55 Nystagmus and other irregular eye movements	0.002	0.997	0.000
H62 Disorders of external ear in diseases classified elsewhere	0.002	0.997	0.000
H27.1 Dislocation of lens	0.002	0.997	0.000
G44 Other headache syndromes	0.000	0.997	0.002
M07.30 Other psoriatic arthropathies (Multiple sites)	0.002	0.998	0.000
H18.5 Hereditary corneal dystrophies	0.000	0.998	0.002
H43.0 Vitreous prolapse	0.002	0.998	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.002	0.998	0.000
R61.1 Generalised hyperhidrosis	0.000	0.998	0.002
Z71.1 Person with feared complaint in whom no diagnosis is made	0.000	0.998	0.002
H47 Other disorders of optic [2nd] nerve and visual pathways	0.002	0.998	0.000
K74 Fibrosis and cirrhosis of liver	0.002	0.998	0.000
M65.34 Trigger finger-Hand	0.000	0.998	0.002
H59.0 Vitreous syndrome following cataract surgery	0.002	0.998	0.000
K75.8 Other specified inflammatory liver diseases	0.002	0.998	0.000
N05.9 Unspecified	0.002	0.998	0.000
N48.3 Priapism	0.002	0.998	0.000
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.000	0.998	0.002
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.000	0.998	0.002
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.000	0.998	0.002
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.000	0.998	0.002
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.002	0.998	0.000
H17 Corneal scars and opacities	0.002	0.998	0.000
K70-K77 Diseases of liver	0.002	0.998	0.000
H34.9 Retinal vascular occlusion, unspecified	0.002	0.998	0.000
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere	0.002	0.998	0.000
H45.1 Endophthalmitis in diseases classified elsewhere	0.002	0.998	0.000
H45.0 Vitreous haemorrhage in diseases classified elsewhere	0.002	0.998	0.000
I68 Cerebrovascular disorders in diseases classified elsewhere	0.002	0.998	0.000
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.002	0.998	0.000
H48.8 Other disorders of optic nerve and visual pathways in diseases classified elsewhere	0.002	0.998	0.000
H48.1 Retrobulbar neuritis in diseases classified elsewhere	0.002	0.998	0.000
H48.0 Optic atrophy in diseases classified elsewhere	0.002	0.998	0.000
H92.1 Otorrhoea	0.002	0.998	0.000
H34.0 Transient retinal artery occlusion	0.002	0.998	0.000
H28 Cataract and other disorders of lens in diseases classified elsewhere	0.002	0.998	0.000
N05 Unspecified nephritic syndrome	0.002	0.998	0.000
N13.3 Other and unspecified hydronephrosis	0.002	0.998	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.002	0.998	0.000
H20.8 Other iridocyclitis	0.002	0.998	0.000
N05.8 Other	0.002	0.998	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.002	0.998	0.000
K76.7 Hepatorenal syndrome	0.002	0.998	0.000
U80.0 Penicillin resistant agent	0.002	0.998	0.000
H34.8 Other retinal vascular occlusions	0.002	0.998	0.000
N17.8 Other acute renal failure	0.002	0.998	0.000
N17.2 Acute renal failure with medullary necrosis	0.002	0.998	0.000
N17.1 Acute renal failure with acute cortical necrosis	0.002	0.998	0.000
H69.9 Eustachian tube disorder, unspecified	0.002	0.998	0.000
K73 Chronic hepatitis, not elsewhere classified	0.002	0.998	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.002	0.998	0.000
K75.2 Nonspecific reactive hepatitis	0.002	0.998	0.000
K75.1 Phlebitis of portal vein	0.002	0.998	0.000
H20.1 Chronic iridocyclitis	0.002	0.998	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.002	0.998	0.000
U89.9 Agent resistant to unspecified antibiotic	0.002	0.998	0.000
Z04.9 Examination and observation for unspecified reason	0.000	0.998	0.002
H57.8 Other specified disorders of eye and adnexa	0.002	0.998	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.002	0.998	0.000
C50.1 Central portion of breast	0.002	0.998	0.000
H15.1 Episcleritis	0.002	0.998	0.000
H20.2 Lens-induced iridocyclitis	0.002	0.998	0.000
M07.38 Other psoriatic arthropathies (Other)	0.002	0.998	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.002	0.998	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.002	0.998	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.002	0.998	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.002	0.998	0.000
H25.8 Other senile cataract	0.002	0.998	0.000
H47.1 Papilloedema, unspecified	0.002	0.998	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.002	0.998	0.000
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.000	0.998	0.002
H59.8 Other postprocedural disorders of eye and adnexa	0.002	0.998	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.002	0.998	0.000
H15.9 Disorder of sclera, unspecified	0.002	0.998	0.000
H15.0 Scleritis	0.002	0.998	0.000
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere	0.002	0.998	0.000
H22.1 Iridocyclitis in other diseases classified elsewhere	0.002	0.998	0.000
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
H62.8 Other disorders of external ear in diseases classified elsewhere	0.002	0.998	0.000
H62.4 Otitis externa in other diseases classified elsewhere	0.002	0.998	0.000
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
H62.2 Otitis externa in mycoses	0.002	0.998	0.000
H62.1 Otitis externa in viral diseases classified elsewhere	0.002	0.998	0.000
H62.0 Otitis externa in bacterial diseases classified elsewhere	0.002	0.998	0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
H16 Keratitis	0.002	0.998	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.002	0.998	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.002	0.998	0.000
G44.3 Chronic posttraumatic headache	0.000	0.998	0.002
G44.1 Vascular headache, not elsewhere classified	0.000	0.998	0.002
N17.0 Acute renal failure with tubular necrosis	0.002	0.998	0.000
T85.6 Mechanical complication of other specified internal prosthetic devices, implants and grafts	0.000	0.998	0.002
H30-H36 Disorders of choroid and retina	0.002	0.998	0.000
S52.60 Fracture of lower end of both ulna and radius (closed)	0.002	0.998	0.000
H28.0 Diabetic cataract	0.002	0.998	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.002	0.998	0.000
H20.9 Iridocyclitis, unspecified	0.002	0.998	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.002	0.998	0.000
K74.4 Secondary biliary cirrhosis	0.002	0.998	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.002	0.998	0.000
K74.1 Hepatic sclerosis	0.002	0.998	0.000
K74.0 Hepatic fibrosis	0.002	0.998	0.000
N05.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
H47.7 Disorder of visual pathways, unspecified	0.002	0.998	0.000
H47.6 Disorders of visual cortex	0.002	0.998	0.000
H47.5 Disorders of other visual pathways	0.002	0.998	0.000
H47.4 Disorders of optic chiasm	0.002	0.998	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.002	0.998	0.000
N48.2 Other inflammatory disorders of penis	0.002	0.998	0.000
G44.4 Drug-induced headache, not elsewhere classified	0.000	0.998	0.002
H15.8 Other disorders of sclera	0.002	0.998	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.000	0.998	0.002
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.002	0.998	0.000
H17.8 Other corneal scars and opacities	0.002	0.998	0.000
H17.1 Other central corneal opacity	0.002	0.998	0.000
H17.0 Adherent leukoma	0.002	0.998	0.000
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.002	0.998	0.000
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.002	0.998	0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations